This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN or ICLR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
AMN vs. ICLR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. ICLR: Which Stock Is the Better Value Option?
Icon PLC (ICLR) Q3 Earnings Match Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and 0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher
by Zacks Equity Research
OncoCyte (OCX) was a big mover last session, as the company saw its shares rise more than 13% on the day.
Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.
4 Momentum Stocks to Pick Despite MedTech Policy Debacle
by Zacks Equity Research
Investors might pay heed to Zacks counsel and hitch the momentum ride to tide over the Obamacare debacle.
4 Large-Cap Medical Device Stocks to Buy Amid Political Woes
by Zacks Equity Research
Investors facing political doldrums can safely place their bets on the Medical Device space on four large-cap medical device stocks that are poised for impressive returns over the next five years.
ICON Public Limited (ICLR) Rises: Stock Adds 6.3% in Session
by Zacks Equity Research
ICON Public Limited Company (ICLR) shares rose over 6% in the last trading session.
5 Healthcare Players Poised to Beat Q3 Earnings Estimates
by Sapna Bagaria
The health care sector has some stocks that are likely to deliver positive earnings surprises this earnings season.
What's Your Stock's Price Target?
by Kevin Matras
Kevin Matras explains how to calculate a stock's price target and how to find stocks currently trading below them. Highlighted stocks include ABTL, AHS, EXPR, FIX and ICLR.
What's Your Stock's Price Target?
by Kevin Matras
Kevin Matras explains how to calculate a stock's price target and how to find stocks currently trading below them. Highlighted stocks include AMCX, TTM, FUN, APTS and ICLR.
Market-Caps and Stock Selection for Maximum Gains
by Kevin Matras
Small-cap stocks are often market leaders, but don't overlook the mid-caps and large-caps. See how that leadership has changed over the years and which one is in the lead now.
Reasons to be Bullish this Earnings Season
by Kevin Matras
With earnings season right around the corner, see what the statistics say is in store for this one. Highlighted stocks include ABG, CAKE, ICLR, NCR and PNC.